About Martine Rothblatt
Martine Rothblatt is a chairperson & CEO at United Therapeutics.
Form D filings name Martine Rothblatt as a director at BETA Technologies.
Martine Rothblatt reports to the SEC as a director or officer of 2 public companies, including BETA Technologies (BETA).
Martine Rothblatt first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Martine Rothblatt in the role, so the role may have started earlier or lasted longer.
UC
United Therapeutics Corp.
Chairperson & CEO
2006 – 2026 · Public company (UTHR)
Key Colleagues at Startups
The people Martine Rothblatt works with at each company, as listed on that company's latest Form D.
BETA Technologies, Inc. · Form D, Apr 16, 2026
BD
Brian Dunkiel
Executive officer
JM
James McConville
Director
CD
Charles Davis
Director
HC
Herman Cueto
Executive officer
KC
Kyle Clark
President and Chief Executive Officer, director
JS
John Slattery
Director
SD
Sean Donovan
Executive officer
JA
John Abele
Director
MS
Mike Stone
Director
DC
David Churchill
Executive officer and director
AG
Amy Gowder
Director